Close-up view of the TherOx AO System showing the user interface, control knobs and equipment housing.
Case Studies

Therox AO System (Now Zoll)

Client Snapshot
Sector: Surgical

Client Snapshot

TherOx AO System

Current standard of care for the most severe heart attacks involves mechanically opening the blocked artery using percutaneous coronary intervention (PCI), otherwise known as angioplasty and stenting.

Rendered image of the TherOx AO System showing the complete oxygenation unit on a wheeled base with integrated controls.

While PCI has reduced early mortality post-heart attack over the past 25 years, significant myocardial tissue (heart muscle) death and sizable scarring may be present even after the left anterior descending (LAD) artery has been stented. This myocardial damage is linked to increased risk of heart failure and long-term mortality2.

SSO2 Therapy is a novel treatment that complements PCI and is designed to minimize myocardial damage caused by acute myocardial infarction in qualifying patients suffering a LAD ST-elevation myocardial infarction (STEMI) event who are treated with primary PCI within 6 hours of symptom onset. SSO2 Therapy delivers superoxygenated arterial blood directly to at-risk myocardial tissue and is performed in the cardiac catheterization laboratory immediately after PCI is completed.

Side view of the TherOx AO oxygenation system showing the treatment chamber, tubing connections and control interface.
Full view of the TherOx AO System positioned next to a technician height reference, showing device scale and configuration.
Three TherOx AO System units in different color schemes displayed side by side to show design variations and configuration options.

Explore Other Case Studies

Technical patent drawing of an implantable orthopedic screw showing internal components and sensing architecture.

StarFish Medical helped Canary Medical develop a smart implantable screw using EIS to monitor fracture healing without repeated imaging.

Lumithera Units

LumiThera chose StarFish Medical for their expertise in navigating the path from late-stage prototype to commercial launch.

Theranostics represent a promising new frontier in cancer treatment, offering hope alongside a unique set of challenges for healthcare providers.

Abstract illustration of the human spine with a glowing focal point in the lumbar region

A leading research institution tackling the challenge of motor neuron degeneration in ALS developed a novel approach to treatment: deliver GDNF-secreting neural progenitor cells directly into the spinal cord to provide sustained neurotrophic support.

Explore Our Services

Illustration of a pencil and ruler

Our multidisciplinary teams have all the in-house capabilities to transform your medical device from concept to final product.

Illustration of a 3D cube

Medical device design and development with a commercial launch focus. See how we support clinical trials and facilitate seamless tech transfers.

Illustration of two speech bubbles

We help you navigate complex regulatory landscapes to achieve commercial success. Explore our integrated approach to quality and regulatory services.